Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression

By Mourilhe P.   Stokes P.E.  

Drug Safety, Vol. 18, Iss. 1, 1998-01 ,pp. : 57-82

Adis International

Access to resources Recommend Favorite

Dopamine receptor binding in major depression: changes before and after treatment with selective serotonin reuptake inhibitors

By Klimke A.   Larisch R.   Janz A.   Vosberg H.   Muuml ller-Gauml rtner H.W.   Gaebel W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 300-300

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression in Children and Adolescents: Practitioner Review

By Sharp Susan C.   Hellings Jessica A.  

Clinical Drug Investigation, Vol. 26, Iss. 5, 2006-01 ,pp. : 247-255

Adis International

Access to resources Recommend Favorite

Combined treatment with serotonin reuptake selective inhibitors in depression (II). Aspects concerning tolerance and toxicity in clinical practice

By Loza A.A.S.   Valverde J.I.F.   Montes M.J.R..   Martiacute nez M.L.D.   Caballero J.L.V..   Docio E.Q.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 292-293

Elsevier

Access to resources Recommend Favorite

Formulary Restriction of Selective Serotonin Reuptake Inhibitors for Depression: Potential Pitfalls

By Hensley P.L.   Nurnberg H.G.  

PharmacoEconomics, Vol. 19, Iss. 10, 2001-01 ,pp. : 973-982

Adis International

Access to resources Recommend Favorite